Abstract

Long-term efficacy of opioids for non-cancer pain is unproven, but risks argue for cautious prescribing. Few data suggest how long or how much opioid can be prescribed for opioid-naïve patients without inadvertently promoting long-term use. To examine the association between initial opioid prescribing patterns and likelihood of long-term use among opioid-naïve patients. Retrospective cohort study; data from Oregon resident prescriptions linked to death certificates and hospital discharges. Patients filling opioid prescriptions between October 1, 2012, and September 30, 2013, with no opioid fills for the previous 365days. Subgroup analyses examined patients under age 45 who did not die in the follow-up year, excluding most cancer or palliative care patients. Exposure: Numbers of prescription fills and cumulative morphine milligram equivalents (MMEs) dispensed during 30days following opioid initiation ("initiation month"). Proportion of patients with six or more opioid fills during the subsequent year ("long-term users"). There were 536,767 opioid-naïve patients who filled an opioid prescription. Of these, 26,785 (5.0%) became long-term users. Numbers of fills and cumulative MMEs during the initiation month were associated with long-term use. Among patients under age 45 using short-acting opioids who did not die in the follow-up year, the adjusted odds ratio (OR) for long-term use among those receiving two fills versus one was 2.25 (95% CI: 2.17, 2.33). Compared to those who received < 120 total MMEs, those who received between 400 and 799 had an OR of 2.96 (95% CI: 2.81, 3.11). Patients initiating with long-acting opioids had a higher risk of long-term use than those initiating with short-acting drugs. Early opioid prescribing patterns are associated with long-term use. While patient characteristics are important, clinicians have greater control over initial prescribing. Our findings may help minimize the risk of inadvertently initiating long-term opioid use.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call